114 related articles for article (PubMed ID: 35842406)
1. Interdependence of glycemic and lipid modulation in cured chronic hepatitis C patients by direct-acting antiviral agents.
Cheng PN; Sun HY; Feng IC; Chiu YC; Wang ST; Tan DC; Chiu HC; Chien SC; Young KC
J Microbiol Immunol Infect; 2023 Feb; 56(1):20-30. PubMed ID: 35842406
[TBL] [Abstract][Full Text] [Related]
2. Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir/elbasvir or ledipasvir/sofosbuvir treatment against chronic HCV infection.
Sun HY; Cheng PN; Tseng CY; Tsai WJ; Chiu YC; Young KC
Gut; 2018 Jul; 67(7):1342-1350. PubMed ID: 28615303
[TBL] [Abstract][Full Text] [Related]
3. Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort Study.
Lee H; Chien RN; Pao LH; Kuo CJ; Huang PH; Chang ML
Cells; 2021 Oct; 10(11):. PubMed ID: 34831156
[TBL] [Abstract][Full Text] [Related]
4. Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients.
Cheng CH; Chu CY; Chen HL; Lin IT; Wu CH; Lee YK; Bair MJ
Front Endocrinol (Lausanne); 2021; 12():799382. PubMed ID: 35095765
[TBL] [Abstract][Full Text] [Related]
5. Triglyceride-rich lipoproteins and insulin resistance in patients with chronic hepatitis C receiving direct-acting antivirals.
Casas-Deza D; Espina S; Martínez-Sapiña A; Del Moral-Bergos R; Garcia-Sobreviela MP; Lopez-Yus M; Calmarza P; Bernal-Monterde V; Arbones-Mainar JM
Atherosclerosis; 2023 Jun; 375():59-66. PubMed ID: 37245427
[TBL] [Abstract][Full Text] [Related]
6. Carotid Intima-media Thickness and Small Dense Low-density Lipoprotein Cholesterol Increase after One Year of Treatment with Direct-acting Antivirals in Patients with Hepatitis C Virus Infection.
Ichikawa T; Miyaaki H; Miuma S; Motoyoshi Y; Narita S; Toda S; Takahashi Y; Honda T; Yajima H; Uehara R; Hino N; Hori T; Hirata R; Taura N; Nakao K
Intern Med; 2019 May; 58(9):1209-1215. PubMed ID: 30626818
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Changes in Chronic Hepatitis C Patients Who Carry IFNL4-ΔG and Achieve Sustained Virologic Response With Direct-Acting Antiviral Therapy.
Emmanuel B; El-Kamary SS; Magder LS; Stafford KA; Charurat ME; Chairez C; McLaughlin M; Hadigan C; Prokunina-Olsson L; O'Brien TR; Masur H; Kottilil S
J Infect Dis; 2020 Jan; 221(1):102-109. PubMed ID: 31504644
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct-acting antivirals.
Nevola R; Rinaldi L; Zeni L; Sasso FC; Pafundi PC; Guerrera B; Marrone A; Giordano M; Adinolfi LE
JGH Open; 2020 Aug; 4(4):713-721. PubMed ID: 32782961
[TBL] [Abstract][Full Text] [Related]
9. The impact of direct-acting antiviral treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients: temporary? permanent?
Özdoğan O; Yaraş S; Ateş F; Üçbilek E; Sezgin O; Altıntaş E
Turk J Gastroenterol; 2020 May; 31(5):384-392. PubMed ID: 32519958
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C Virus Eradication with New Interferon-Free Treatment Improves Metabolic Profile in Hepatitis C Virus-Related Liver Transplant Recipients.
Beig J; Orr D; Harrison B; Gane E
Liver Transpl; 2018 Aug; 24(8):1031-1039. PubMed ID: 29577581
[TBL] [Abstract][Full Text] [Related]
11. Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study.
Colussi G; Donnini D; Brizzi RF; Maier S; Valenti L; Catena C; Cavarape A; Sechi LA; Soardo G
World J Gastroenterol; 2019 Oct; 25(40):6094-6106. PubMed ID: 31686765
[TBL] [Abstract][Full Text] [Related]
12. The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.
Jung HJ; Kim YS; Kim SG; Lee YN; Jeong SW; Jang JY; Lee SH; Kim HS; Kim BS
Clin Mol Hepatol; 2014 Mar; 20(1):38-46. PubMed ID: 24757657
[TBL] [Abstract][Full Text] [Related]
13. Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience.
Dalbeni A; Villani R; Bevilacqua M; Sacco F; Faccincani D; Cattazzo F; Cavallone F; Mantovani A; Ceruti V; Ieluzzi D; Paon V; Mantovani A; Serviddio G; Sacerdoti D
J Dig Dis; 2022 May; 23(5-6):324-330. PubMed ID: 35700113
[TBL] [Abstract][Full Text] [Related]
14. IL28B gene polymorphism is correlated with changes in low-density lipoprotein cholesterol levels after clearance of hepatitis C virus using direct-acting antiviral treatment.
Morihara D; Ko YL; Shibata K; Yamauchi R; Fukuda H; Tsuchiya N; Fukunaga A; Kunimoto H; Iwashita H; Takata K; Tanaka T; Sakurai K; Inomata S; Yokoyama K; Nishizawa S; Takeyama Y; Irie M; Shakado S; Sohda T; Sakisaka S
J Gastroenterol Hepatol; 2019 Nov; 34(11):2019-2027. PubMed ID: 31144350
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis.
Petta S; Adinolfi LE; Fracanzani AL; Rini F; Caldarella R; Calvaruso V; Cammà C; Ciaccio M; Di Marco V; Grimaudo S; Licata A; Marrone A; Nevola R; Pipitone RM; Pinto A; Rinaldi L; Torres D; Tuttolomondo A; Valenti L; Fargion S; Craxì A
J Hepatol; 2018 Jul; 69(1):18-24. PubMed ID: 29505844
[TBL] [Abstract][Full Text] [Related]
16. Lipids, glucose and iron metabolic alterations in chronic hepatitis C after viral eradication - comparison of the new direct-acting antiviral agents with the old regimens.
Carvalho JR; Velosa J; Serejo F
Scand J Gastroenterol; 2018; 53(7):857-863. PubMed ID: 29779403
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis.
Graf C; Welzel T; Bogdanou D; Vermehren J; Beckel A; Bojunga J; Friedrich-Rust M; Dietz J; Kubesch A; Mondorf A; Fischer S; Lutz T; Stoffers P; Herrmann E; Poynard T; Zeuzem S; Dultz G; Mihm U
J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32825571
[TBL] [Abstract][Full Text] [Related]
18. Reverse inflammaging: Long-term effects of HCV cure on biological age.
Oltmanns C; Liu Z; Mischke J; Tauwaldt J; Mekonnen YA; Urbanek-Quaing M; Debarry J; Maasoumy B; Wedemeyer H; Kraft ARM; Xu CJ; Cornberg M
J Hepatol; 2023 Jan; 78(1):90-98. PubMed ID: 36152762
[TBL] [Abstract][Full Text] [Related]
19. INCREASE OF LIPIDS DURING HCV TREATMENT: VIRUS ACTION OR MEDICATION?
Andrade VG; Yamashiro FDS; Oliveira CV; Kurozawa LL; Moreira A; Silva GF
Arq Gastroenterol; 2018; 55(2):184-187. PubMed ID: 30043871
[TBL] [Abstract][Full Text] [Related]
20. No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV.
Chaudhury CS; Sheehan J; Chairez C; Akoth E; Gross C; Silk R; Kattakuzhy S; Rosenthal E; Kottilil S; Masur H; Hadigan C
J Infect Dis; 2017 Dec; 217(1):47-50. PubMed ID: 29161418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
